Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Hillard

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Maturitas|June 11, 2015
Depression and the incidence of urinary incontinence symptoms among young women: Results from a prospective cohort studyGita D Mishra, Megan S Barker, Gerrie-Cor Herber-Gast, et al.
Menopause International|December 20, 2007
Prevention and treatment of osteoporosis in women, Farook Al-Azzawi, David Barlow, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 9, 2026
Modern Management of the Menopause: Are We Measuring What Matters?Joscelyn Gan, Michelle Steeper, Tim Hillard, et al.
Post Reproductive Health|April 13, 2025
Feasibility of developing a new tool for assessing vaginal health in women with Genitourinary Syndrome of Menopause; The VAN studyPaula Briggs, Christopher Evans, Steven Lane, et al.
Climacteric : the Journal of the International Menopause Society|July 17, 2024
Management of obesity in menopauseSantiago Palacios, Peter Chedraui, Rafael Sanchez-Borrego, et al.
Post Reproductive Health|April 21, 2022
Consensus-led recommendations supporting choice and personalisation of Hormone replacement therapy in menopause carePaula Briggs, Katie Barber, Kathie Cooke, et al.
Post Reproductive Health|January 18, 2021
BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020Haitham Hamoda, Susan R Davis, Antonio Cano, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 6, 2003
A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetatePatrick Neven, Tore Lunde, Pierluigi Benedetti-Panici, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 1, 2025
Factors Associated With Non-Vasomotor Menopause Symptoms Experienced by 7285 Women: A UK-Wide National SurveyRhianna Davies, Ashwin Goyal, Zachary Nash, et al.
Menopause (New York, N.Y.)|April 27, 2021
A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiativeSarah Lensen, David Archer, Robin J Bell, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Maturitas|June 11, 2015
Depression and the incidence of urinary incontinence symptoms among young women: Results from a prospective cohort studyGita D Mishra, Megan S Barker, Gerrie-Cor Herber-Gast, et al.
Menopause International|December 20, 2007
Prevention and treatment of osteoporosis in women, Farook Al-Azzawi, David Barlow, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 9, 2026
Modern Management of the Menopause: Are We Measuring What Matters?Joscelyn Gan, Michelle Steeper, Tim Hillard, et al.
Post Reproductive Health|April 13, 2025
Feasibility of developing a new tool for assessing vaginal health in women with Genitourinary Syndrome of Menopause; The VAN studyPaula Briggs, Christopher Evans, Steven Lane, et al.
Climacteric : the Journal of the International Menopause Society|July 17, 2024
Management of obesity in menopauseSantiago Palacios, Peter Chedraui, Rafael Sanchez-Borrego, et al.
Post Reproductive Health|April 21, 2022
Consensus-led recommendations supporting choice and personalisation of Hormone replacement therapy in menopause carePaula Briggs, Katie Barber, Kathie Cooke, et al.
Post Reproductive Health|January 18, 2021
BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020Haitham Hamoda, Susan R Davis, Antonio Cano, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 6, 2003
A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetatePatrick Neven, Tore Lunde, Pierluigi Benedetti-Panici, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 1, 2025
Factors Associated With Non-Vasomotor Menopause Symptoms Experienced by 7285 Women: A UK-Wide National SurveyRhianna Davies, Ashwin Goyal, Zachary Nash, et al.
Menopause (New York, N.Y.)|April 27, 2021
A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiativeSarah Lensen, David Archer, Robin J Bell, et al.
Pageof 4